<description value="Other medicinal products that have been reported to increase the potential
toxicity of parenterally administered aminoglycosides include:\n- amphotericin B,
cefalotin, ciclosporin, tacrolimus, polymyxins (risk of increased nephrotoxicity);\n-
platinum compounds (risk of increased nephrotoxicity and ototoxicity);\n-
anticholinesterases, botulinum toxin (neuromuscular effects)."/>